COMMUNIQUÉS West-GlobeNewswire
-
New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms
30/04/2026 -
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
30/04/2026 -
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
30/04/2026 -
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
30/04/2026 -
Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment
30/04/2026 -
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
30/04/2026 -
Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations
30/04/2026 -
Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors
30/04/2026 -
Living Carbon secures $500m deal with Octopus Energy Generation to restore degraded land and remove CO₂
30/04/2026 -
YouthCommerce Unveils PhiFlow: A Revolutionary Operating Standard for Clinics
30/04/2026 -
Willow Glow Wellness Spa Clinics Announces Advanced LED Facelift Protocol, Attracting Silicon Valley Clients for Non-Surgical Skin Rejuvenation
30/04/2026 -
Psychemedics Releases 2026 Workforce Insights Report
30/04/2026 -
Centre for Neuro Skills CEO David Harrington Joins Brain to Brain Podcast to Discuss the Science of Recovery, Advocacy for Brain Injury Care and Why It Is Never Too Late
30/04/2026 -
TimelyCare Expands Its Basic Needs Service to Help Colleges Better Support Student Retention
30/04/2026 -
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
30/04/2026 -
Vireo Growth to Acquire FLUENT in All-Stock Transaction
30/04/2026 -
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
30/04/2026 -
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
30/04/2026 -
BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ET
30/04/2026
Pages